News tagged with cancer immunotherapy
Experimental vaccine sets sights on lung cancer
An experimental immunotherapy may someday become the newest weapon against lung cancer. Physician-scientists from Weill Cornell Medical College and Columbia University Medical Center are enrolling patients with non-small ...
Nov 30, 2010 |
5 / 5 (2) |
0
Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment
Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a jour ...
Jun 15, 2010 |
4 / 5 (1) |
0
'Scout scans' map the way in non-Hodgkin's lymphoma treatment
According to a study presented at SNM's 57th Annual Meeting, molecular imaging can evaluate and optimize non-Hodgkin's lymphoma therapy with Zevalin, a front-line radioimmunotherapy drug that uses a dose of radioactive material ...
Jun 07, 2010 |
not rated yet |
0
Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators ...
Jun 01, 2010 |
not rated yet |
0
Clue to switch of bladder cancer from locally contained to invasive found
Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become ...
May 14, 2010 |
not rated yet |
0
IMPACT results show potential cancer treatment
Dr. Neal Shore (GB) presented for the first time in Europe the updated results of the study "Sipuleucel-T Active Cellular Immunotherapy for Metastatic, Castration-Resistant Prostate Cancer: results from the IMPACT trial," ...
Apr 19, 2010 |
not rated yet |
0
Scientists discover how to improve immune response to cancer
A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer ...
Apr 26, 2009 |
5 / 5 (6) |
0
Genetic variants predict recurrence of bladder cancer, patient survival
Scientists at The University of Texas M. D. Anderson Cancer Center have discovered genetic variations in the inflammation pathway that reduce the likelihood of recurrence and increase survival of patients with non-muscle ...
Apr 20, 2009 |
not rated yet |
0
